Peptide therapy TikTok claims vs. what the research says

What did @eqnxlabs actually say?

Not much, honestly. The creator isn't making claims here — they're shopping for reviews. They mention having ADHD and wanting to try "C-Max" (almost certainly Semax, a synthetic peptide derived from ACTH) and reference "C-Lank" (Selank, a tuftsin-based anxiolytic peptide). They say they want "real genuine, I actually take it reviews" and explicitly don't want to be sold anything. That's a reasonable ask. But the framing — "I just really want to see how it works for me" in the context of ADHD — carries an implicit assumption that these peptides do something for ADHD worth talking about. That assumption is worth examining.

To be clear: the creator does not claim Semax treats ADHD, does not recommend a dose, and does not make therapeutic promises. This is more of a crowdsourcing post than a health claim. Still, the subtext matters on a platform where 17,900 people watched it.

Does the science back this up?

There is real research on Semax and Selank, mostly from Russian institutions, and it's more substantive than you'd expect for peptides being discussed on TikTok. But calling it robust would be generous.

Semax (Met-Glu-His-Phe-Pro-Gly-Pro) has been studied as a nootropic and neuroprotective agent in Russia since the 1980s. It appears to increase brain-derived neurotrophic factor (BDNF) and has shown effects on dopaminergic and serotonergic transmission in animal models. Dolotov et al. (2006, Journal of Neurochemistry) reported BDNF-related activity in rodents. A handful of small Russian clinical trials have examined Semax in stroke recovery and attention-related conditions, but these studies are often not peer-reviewed in Western journals, use small samples, and lack placebo controls rigorous enough to meet current standards.

For ADHD specifically? There are no published randomized controlled trials. Zero. The ADHD angle is extrapolated from Semax's dopaminergic activity, which is a logical leap, not a clinical finding. Selank has similarly thin evidence, with some anxiolytic properties observed in animal models (Semenova et al., 2010, CNS Drug Reviews), but nothing specific to ADHD.

What did they get wrong (or right)?

They didn't get anything factually wrong because they didn't make factual claims. Credit where it's due: asking for unbiased user reviews rather than taking a manufacturer's word for it is a better epistemological starting point than most peptide content on TikTok.

What's missing, though, is acknowledgment that anecdotal reviews have real limits. Semax users who report improved focus, reduced brain fog, or calmer attention are experiencing something — placebo effect, real nootropic activity, or both — but self-reported outcomes from an uncontrolled, non-blinded user base can't tell you which. The creator treats "real genuine reviews" as reliable data. They aren't, not in any clinical sense.

There's also a sourcing issue worth flagging. Semax and Selank are not FDA-approved. In the U.S., they exist in a gray zone, sometimes sold as research chemicals or compounded peptides. Quality and purity vary significantly across suppliers. The creator doesn't mention this at all, and their audience probably doesn't know it either.

What should you actually know?

If you have ADHD and you're curious about Semax, here's the honest picture. There is a plausible biological rationale. Semax does appear to modulate dopamine and BDNF pathways. ADHD involves dopamine dysregulation. Those two facts can coexist without Semax being a proven ADHD treatment, because the gap between "affects dopamine in rats" and "helps humans with ADHD" is enormous and mostly uncrossed in the literature.

Selank's appeal for ADHD likely comes from its anxiolytic profile. Many people with ADHD experience comorbid anxiety, and something that reduces anxiety might help them function better. That's a reasonable hypothesis. It's not a treatment.

Both peptides require refrigeration, injectable administration in research-grade forms, or intranasal delivery. Neither is something you should be dosing based on TikTok comment sections, regardless of how genuine those reviews sound. If you're considering either peptide, that conversation belongs with a licensed clinician who can review your full health picture, not with strangers online validating your excitement.

• Semax has some legitimate preclinical research behind it, mostly from Russian sources
• No RCTs exist for either peptide in ADHD populations
• Anecdotal reviews, however genuine, cannot substitute for controlled evidence
• Regulatory status in the U.S. means sourcing and purity are real concerns